Simplex Trading, LLC Connect Biopharma Holdings LTD Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$1.01 - $1.74 $81 - $140	81 New	81 $0
Q4 2022 Feb 02, 2023	BUY	$0.64 - $1.31 $58 - $119	91 Added 10.08%	994 $0
Q3 2022 Nov 04, 2022	BUY	$0.8 - $1.65 $722 - $1,489	903 New	903 $1,000
Q2 2022 Aug 03, 2022	SELL	$0.56 - $3.25 $702 - $4,078	-1,255 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$2.46 - $5.92 $17,163 - $41,303	-6,977 Reduced 84.75%	1,255 $3,000
Q4 2021 Feb 23, 2022	BUY	$4.26 - $23.33 $35,068 - $192,052	8,232 New	8,232 $42,000

3.05M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $54.5M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.